Title : Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy.

Pub. Date : 2017 Jun 8

PMID : 28593948






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 PEG engager enhances the anti-proliferative activity of PEG-liposomal doxorubicin to EGFR+ TNBC cells by up to 100-fold with potency dependent on EGFR expression levels. Doxorubicin epidermal growth factor receptor Homo sapiens
2 PEG engager enhances the anti-proliferative activity of PEG-liposomal doxorubicin to EGFR+ TNBC cells by up to 100-fold with potency dependent on EGFR expression levels. Doxorubicin epidermal growth factor receptor Homo sapiens